Departure. Clinical Miss. Billion: Should You Bet on Pfizer?
Pfizer faces a trio of headwinds: a CFO departure, a clinical miss, and a billion-dollar bet on Seagen. This article ...
Protecting your crypto investments from theft is vital. Explore various methods to enhance the security of your digital assets.
22,828 articlesPfizer faces a trio of headwinds: a CFO departure, a clinical miss, and a billion-dollar bet on Seagen. This article ...
Investors are eyeing the nascent field of quantum computing for dramatic upside. This guide breaks down three notable...
Investors are shifting from traditional savings toward monthly dividend ETFs offering higher yields. This report brea...
The world runs on chips, and ON Semiconductor sits at an important crossroads of EVs, automation, and data centers. T...
A Live Oak Bancshares director sold 8,400 shares for about $336,000. Learn what this kind of insider action can signa...
A fresh stake from Cross Staff Investments in the Akre Focus ETF could signal a manager’s confidence in Akre’s approa...
With markets volatile in May 2026, delaying Social Security to age 70 can raise lifetime benefits. The breakeven poin...
Broadcom is riding a powerful AI wave, with revenue in key AI-adjacent areas jumping. Yet the stock moved lower after...
In February, Figma exhibited a notable stock move as investor interest focused on cloud-based collaboration tools. Th...
When Valens Semiconductor released its first-quarter results, investors pushed valuations higher. This article breaks...
A celebrity fragrance launch is more than a scent—it's a financial move. See how khloé kardashian launches blue lever...
In February, Fluor Corp. shares kept climbing as demand for infrastructure and energy projects stayed resilient. This...